Collectively, these data suggest that cancers arising in germline BRCA2 mutation carriers frequently fail to exhibit loss of the wildtype allele, and that failure to exhibit LOH occurs in BRCA2‐mutant cancers from several different tissues. Here, BRCA2 is linked to cancer.